REBECCA LEYNES: Open Payments
NPI 1063643740 · SPRING HILL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,826 in 97 payments from 20 companies in 2025. Trend: 2023 $2,268 · 2024 $2,141 · 2025 $2,826
Food & beverage: $2,659Education: $167
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $429 |
| ABBVIE INC. | 16 | $379 |
| Botanix SB Inc | 8 | $349 |
| Novartis Pharmaceuticals Corporation | 9 | $282 |
| Janssen Biotech, Inc. | 13 | $241 |
| UCB, Inc. | 8 | $213 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $178 |
| E.R. Squibb & Sons, L.L.C. | 3 | $122 |
| Amgen Inc. | 5 | $114 |
Products named: DUPIXENT, SOFDRA, TREMFYA, Bimzelx, SKYRIZI, SPEVIGO, RINVOQ, Rhapsido.
Industry payments across FL — which companies pay providers there.
